01477nas a2200193   4500008003900000245012700039210006900166260000800235300000600243490000700249520085600256653004101112653002501153653001301178653002101191653001001212100001601222856004501238       2015                          d00aEngraftment Syndrome after Autologous Stem Cell Transplantation: An Update Unifying the Definition and Management Approach0 aEngraftment Syndrome after Autologous Stem Cell Transplantation   cDec  a10 v213 aEngraftment syndrome (ES) encompasses a continuum of periengraftment complications after autologous hematopoietic stem cell transplantation. ES may include noninfectious fever, skin rash, diarrhea, hepatic dysfunction, renal dysfunction, transient encephalopathy, and capillary leak features, such as noncardiogenic pulmonary infiltrates, hypoxia, and weight gain with no alternative etiologic basis other than engraftment. Given its pleiotropic clinical presentation, the transplant field has struggled to clearly define ES and related syndromes. Here, we present a comprehensive review of ES in all documented disease settings. Furthermore, we discuss the proposed risk factors, etiology, and clinical relevance of ES. Finally, our current approach to ES is included along with a proposed treatment algorithm for the management of this complication.10aAutologous graft-versus-host disease10aEngraftment syndrome10aLymphoma10aMultiple Myeloma10aPOEMS1 aCornell, RF  uhttp://613633.bywedr.asia/reference/4621